Literature DB >> 9353183

Recent advances in chemoprevention of cancer.

W K Hong1, M B Sporn.   

Abstract

Chemoprevention is the use of pharmacologic or natural agents that inhibit the development of invasive cancer either by blocking the DNA damage that initiates carcinogenesis or by arresting or reversing the progression of premalignant cells in which such damage has already occurred. Recent advances in our understanding of the mechanisms of carcinogenesis have led to the synthesis of new drugs that can inhibit tumor development in experimental animals by selective action on specific molecular targets, such as the estrogen, androgen, and retinoid receptors or inducible cyclooxygenase. Several of these agents (including tamoxifen, 13-cis-retinoic acid, retinyl palmitate, and an acyclic retinoid) are clinically effective in preventing the development of cancer, particularly in patients who are at high risk for developing second primary tumors after surgical removal of the initial tumor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353183     DOI: 10.1126/science.278.5340.1073

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  118 in total

Review 1.  Genetic progression in the pancreatic ducts.

Authors:  R H Hruban; R E Wilentz; S E Kern
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

2.  Chemopreventive effect of oltipraz on AFB(1)-induced hepatocarcinogenesis in tree shrew model.

Authors:  Yuan Li; Jian-Jia Su; Liu-Liang Qin; Chun Yang; Dan Luo; Ke-Chen Ban; TW Kensler; BD Roebuck
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

Review 3.  Novel agents for chemoprevention, screening methods, and sampling issues.

Authors:  Mary Jo Fackler; Ella Evron; Seema A Khan; Saraswati Sukumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-01       Impact factor: 2.673

Review 4.  Retinoid pathway and cancer therapeutics.

Authors:  Nathan Bushue; Yu-Jui Yvonne Wan
Journal:  Adv Drug Deliv Rev       Date:  2010-08-03       Impact factor: 15.470

5.  A black raspberry extract inhibits proliferation and regulates apoptosis in cervical cancer cells.

Authors:  Zhaoxia Zhang; Thomas J Knobloch; Leigh G Seamon; Gary D Stoner; David E Cohn; Electra D Paskett; Jeffrey M Fowler; Christopher M Weghorst
Journal:  Gynecol Oncol       Date:  2011-08-09       Impact factor: 5.482

6.  Inhibitory effect of 1-O (2 methoxy) hexadecyl glycerol and phenylbutyrate on the malignant properties of human prostate cancer cells.

Authors:  S Reynolds; H Cederberg; S Chakrabarty
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

7.  Isosilybin A induces apoptosis in human prostate cancer cells via targeting Akt, NF-κB, and androgen receptor signaling.

Authors:  Gagan Deep; Subhash C Gangar; Nicholas H Oberlies; David J Kroll; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2010-10       Impact factor: 4.784

8.  Cell-cycle inhibition and apoptosis induced by curcumin and cisplatin or oxaliplatin in human ovarian carcinoma cells.

Authors:  M Montopoli; E Ragazzi; G Froldi; L Caparrotta
Journal:  Cell Prolif       Date:  2009-02-18       Impact factor: 6.831

9.  In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.

Authors:  Francesca De Amicis; Alessandra Russo; Paola Avena; Marta Santoro; Adele Vivacqua; Daniela Bonofiglio; Loredana Mauro; Saveria Aquila; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

10.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.